We are leading provider of Spravato (Esketamine), a medication approved by the FDA for the treatment of depression, Specialized in using Spravato to help patients manage their symptoms and improve their quality of life.
Spravato is a medication derived from ketamine and approved by the FDA for the treatment of depression. It is administered as a nasal spray and has rapid and long-lasting effects in treating depression and reducing the risk of suicide.
We offer Spravato treatments under the supervision of a trained medical professional.
A trained medical professional administers our Spravato treatments in a safe and controlled environment.
During and after the treatment, patients will be closely monitored for safety and comfort.
Our team of experts will work with each patient to develop a personalized treatment plan that is tailored to their individual needs and goals.
Spravato works by blocking the brain’s N-methyl-D-aspartate (NMDA) receptors, which regulate mood and perception. This results in changes in the brain’s neurotransmitter levels, leading to improved symptoms of depression.
Spravato has been shown to have rapid and long-lasting effects in treating depression and reducing the risk of suicide. Spravato treatment include.
Spravato can produce noticeable improvements in symptoms within just a few hours.
Sustained improvement in symptoms for weeks or even months after a Spravato treatment.
Spravato has been approved by the FDA for the treatment of depression and has a safety profile.
Eximious Integrated offers a safe space for the treatment of psychiatric disorders, with over 20 years of experience. At Eximious, we offer a full range of integrated mental health services to meet the diverse .
© 2023 Eximious Integrated Health Solutions. All rights reserved.
